'The urgency is increasing': Moderna spotlights vaccine, orphan drug programs, as it plots growth beyond Covid

At its R&D day two years ago, Moderna was still anxiously awaiting Phase III data on its Covid-19 vaccine. In a preview, CEO Stéphane Bancel …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

'The ur­gency is in­creas­ing': Mod­er­na spot­lights vac­cine, or­phan drug pro­grams, as it plots growth be­yond Covid